Male breast cancer in BRCA1 and BRCA2 mutation carriers : pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Show full item record



Permalink

http://hdl.handle.net/10138/208453

Citation

Silvestri , V , Barrowdale , D , Mulligan , A M , Neuhausen , S L , Fox , S , Karlan , B Y , Mitchell , G , James , P , Thull , D L , Zorn , K K , Carter , N J , Nathanson , K L , Dornchek , S M , Rebbeck , T R , Ramus , S J , Nussbaum , R L , Olopade , O I , Rantala , J , Yoon , S-Y , Caligo , M A , Spugnesi , L , Bojesen , A , Pedersen , I S , Thomassen , M , Jensen , U B , Toland , A E , Senter , L , Andrulis , I L , Glendon , G , Hulick , P J , Irnyanitov , E N , Greene , M H , Mai , P L , Singer , C F , Rappaport-Fuerhauser , C , Kramer , G , Vijai , J , Offit , K , Robson , M , Lincoln , A , Jacobs , L , Machackova , E , Foretova , L , Navratilova , M , Vasickova , P , Couch , F J , Hallberg , E , Ruddy , K J , Sharma , P , Kim , S-W , Teixeira , M R , Pinte , P , Montagna , M , Matricardi , L , Arason , A , Johannsson , O T , Barkardottir , R B , Jakubowska , A , Lubinski , J , Izquierdo , A , Angel Pujana , M , Balmana , J , Diez , O , Ivady , G , Papp , J , Olah , E , Kwong , A , Nevanlinna , H , Aittomaki , K , Perez Segura , P , Caldes , T , Van Maerken , T , Poppe , B , Claes , K B M , Isaacs , C , Elan , C , Lasset , C , Stoppa-Lyonnet , D , Barjhoux , L , Belotti , M , Meindl , A , Gehrig , A , Sutter , C , Enger , C , Niederacher , D , Steinemann , D , Hahnen , E , Kast , K , Arnold , N , Varon-Mateeva , R , Wand , D , Godwin , A K , Evans , D G , Frost , D , Perkins , J , Adlard , J , Izatt , L , Platte , R , Eeles , R , Ellis , S , Hamann , U , Garber , J , Fostira , F , Fountzilas , G , Pasini , B , Giannini , G , Rizzolo , P , Russo , A , Cortesi , L , Papi , L , Varesco , L , Palli , D , Zanna , I , Savarese , A , Radice , P , Manoukian , S , Peissel , B , Barile , M , Bonanni , B , Viel , A , Pensotti , V , Tommasi , S , Peterlongo , P , Weitzel , J N , Osorio , A , Benitez , J , McGuffog , L , Healey , S , Gerdes , A-M , Ejlertsen , B , Hansen , T V O , Steele , L , Ding , Y C , Tung , N , Janavicius , R , Goldgar , D E , Buys , S S , Daly , M B , Bane , A , Terry , M B , John , E M , Southey , M , Easton , D F , Chenevix-Trench , G , Antoniou , A C , Ottini , L , kConFab Investigators , Hereditary Breast Ovarian Canc Res & EMBRACE 2016 , ' Male breast cancer in BRCA1 and BRCA2 mutation carriers : pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 ' Breast Cancer Research , vol. 18 , 15 . DOI: 10.1186/s13058-016-0671-y

Title: Male breast cancer in BRCA1 and BRCA2 mutation carriers : pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Author: Silvestri, Valentina; Barrowdale, Daniel; Mulligan, Anna Marie; Neuhausen, Susan L.; Fox, Stephen; Karlan, Beth Y.; Mitchell, Gillian; James, Paul; Thull, Darcy L.; Zorn, Kristin K.; Carter, Natalie J.; Nathanson, Katherine L.; Dornchek, Susan M.; Rebbeck, Timothy R.; Ramus, Susan J.; Nussbaum, Robert L.; Olopade, Olufunrnilayo I.; Rantala, Johanna; Yoon, Sook-Yee; Caligo, Maria A.; Spugnesi, Laura; Bojesen, Anders; Pedersen, Inge Sokilde; Thomassen, Muds; Jensen, Uffe Birk; Toland, Amanda Ewart; Senter, Leigha; Andrulis, Irene L.; Glendon, Gord; Hulick, Peter J.; Irnyanitov, Evgeny N.; Greene, Mark H.; Mai, Phuong L.; Singer, Christian F.; Rappaport-Fuerhauser, Christine; Kramer, Gero; Vijai, Joseph; Offit, Kenneth; Robson, Mark; Lincoln, Anne; Jacobs, Lauren; Machackova, Eva; Foretova, Lenka; Navratilova, Marie; Vasickova, Petra; Couch, Fergus J.; Hallberg, Emily; Ruddy, Kathryn J.; Sharma, Priyanka; Kim, Sung-Won; Teixeira, Manuel R.; Pinte, Pedro; Montagna, Marco; Matricardi, Laura; Arason, Adalgeir; Johannsson, Oskar Th; Barkardottir, Rosa B.; Jakubowska, Anna; Lubinski, Jan; Izquierdo, Angel; Angel Pujana, Miguel; Balmana, Judith; Diez, Orland; Ivady, Gabriella; Papp, Janos; Olah, Edith; Kwong, Ava; Nevanlinna, Heli; Aittomaki, Kristiina; Perez Segura, Pedro; Caldes, Trinidad; Van Maerken, Tom; Poppe, Bruce; Claes, Kathleen B. M.; Isaacs, Claudine; Elan, Camille; Lasset, Christine; Stoppa-Lyonnet, Dominique; Barjhoux, Laure; Belotti, Muriel; Meindl, Alfons; Gehrig, Andrea; Sutter, Christian; Enger, Christoph; Niederacher, Dieter; Steinemann, Doris; Hahnen, Eric; Kast, Karin; Arnold, Norbert; Varon-Mateeva, Raymonda; Wand, Dorothea; Godwin, Andrew K.; Evans, D. Gareth; Frost, Debra; Perkins, Jo; Adlard, Julian; Izatt, Louise; Platte, Radka; Eeles, Ros; Ellis, Steve; Hamann, Ute; Garber, Judy; Fostira, Florentia; Fountzilas, George; Pasini, Barbara; Giannini, Giuseppe; Rizzolo, Piera; Russo, Antonio; Cortesi, Laura; Papi, Laura; Varesco, Liliana; Palli, Domenico; Zanna, Ines; Savarese, Antonella; Radice, Paolo; Manoukian, Siranoush; Peissel, Bernard; Barile, Monica; Bonanni, Bernardo; Viel, Alessandra; Pensotti, Valeria; Tommasi, Stefania; Peterlongo, Paolo; Weitzel, Jeffrey N.; Osorio, Ana; Benitez, Javier; McGuffog, Lesley; Healey, Sue; Gerdes, Anne-Marie; Ejlertsen, Bent; Hansen, Thomas V. O.; Steele, Linda; Ding, Yuan Chun; Tung, Nadine; Janavicius, Ramunas; Goldgar, David E.; Buys, Saundra S.; Daly, Mary B.; Bane, Anita; Terry, Mary Beth; John, Esther M.; Southey, Melissa; Easton, Douglas F.; Chenevix-Trench, Georgia; Antoniou, Antonis C.; Ottini, Laura; kConFab Investigators; Hereditary Breast Ovarian Canc Res; EMBRACE
Contributor: University of Helsinki, Department of Obstetrics and Gynegology
University of Helsinki, Department of Medical and Clinical Genetics
Date: 2016-02-09
Language: eng
Number of pages: 13
Belongs to series: Breast Cancer Research
ISSN: 1465-542X
URI: http://hdl.handle.net/10138/208453
Abstract: Background: BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of breast cancers (BCs) in men with BRCA1/2 mutations. Using the largest available dataset, we determined whether MBCs arising in BRCA1/2 mutation carriers display specific pathologic features and whether these features differ from those of BRCA1/2 female BCs (FBCs). Methods: We characterised the pathologic features of 419 BRCA1/2 MBCs and, using logistic regression analysis, contrasted those with data from 9675 BRCA1/2 FBCs and with population-based data from 6351 MBCs in the Surveillance, Epidemiology, and End Results (SEER) database. Results: Among BRCA2 MBCs, grade significantly decreased with increasing age at diagnosis (P = 0.005). Compared with BRCA2 FBCs, BRCA2 MBCs were of significantly higher stage (P for trend = 2 x 10(-5)) and higher grade (P for trend = 0.005) and were more likely to be oestrogen receptor-positive [odds ratio (OR) 10.59; 95 % confidence interval (CI) 5.15-21.80] and progesterone receptor-positive (OR 5.04; 95 % CI 3.17-8.04). With the exception of grade, similar patterns of associations emerged when we compared BRCA1 MBCs and FBCs. BRCA2 MBCs also presented with higher grade than MBCs from the SEER database (P for trend = 4 x 10(-12)). Conclusions: On the basis of the largest series analysed to date, our results show that BRCA1/2 MBCs display distinct pathologic characteristics compared with BRCA1/2 FBCs, and we identified a specific BRCA2-associated MBC phenotype characterised by a variable suggesting greater biological aggressiveness (i.e., high histologic grade). These findings could lead to the development of gender-specific risk prediction models and guide clinical strategies appropriate for MBC management.
Subject: Male breast cancer
BRCA1/2
Pathology
Histologic grade
Genotype-phenotype correlations
POPULATION
RISK
CARCINOMA
FEATURES
GRADE
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
s13058_016_0671_y.pdf 765.6Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record